- Home
- HRMY vs THS Comparison
HRMY vs THS Comparison
Compare HRMY & THS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- THS
- Stock Information
- Founded
- HRMY 2017
- THS 2021
- Country
- HRMY United States
- THS United States
- Employees
- HRMY N/A
- THS N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- THS Packaged Foods
- Sector
- HRMY Health Care
- THS Consumer Staples
- Exchange
- HRMY Nasdaq
- THS Nasdaq
- Market Cap
- HRMY 2.0B
- THS 1.1B
- IPO Year
- HRMY 2020
- THS N/A
- Fundamental
- Price
- HRMY $32.16
- THS $20.90
- Analyst Decision
- HRMY Strong Buy
- THS Hold
- Analyst Count
- HRMY 9
- THS 6
- Target Price
- HRMY $54.22
- THS $27.83
- AVG Volume (30 Days)
- HRMY 620.8K
- THS 657.7K
- Earning Date
- HRMY 08-05-2025
- THS 08-04-2025
- Dividend Yield
- HRMY N/A
- THS N/A
- EPS Growth
- HRMY 13.13
- THS N/A
- EPS
- HRMY 2.62
- THS 0.13
- Revenue
- HRMY $744,852,000.00
- THS $3,325,300,000.00
- Revenue This Year
- HRMY $20.10
- THS $1.10
- Revenue Next Year
- HRMY $18.01
- THS $1.65
- P/E Ratio
- HRMY $12.27
- THS $157.75
- Revenue Growth
- HRMY 20.62
- THS N/A
- 52 Week Low
- HRMY $26.47
- THS $19.29
- 52 Week High
- HRMY $41.61
- THS $43.84
- Technical
- Relative Strength Index (RSI)
- HRMY 43.25
- THS 47.71
- Support Level
- HRMY $31.70
- THS $19.29
- Resistance Level
- HRMY $33.69
- THS $21.59
- Average True Range (ATR)
- HRMY 0.89
- THS 0.77
- MACD
- HRMY -0.10
- THS 0.10
- Stochastic Oscillator
- HRMY 37.30
- THS 65.98
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About THS Treehouse Foods Inc.
TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages and drink mixes (such as nondairy creamer, coffee, tea, broth), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.